Krell; Hans-Willi
Patent Applications and Registrations
Patent applications and USPTO patent grants for Krell; Hans-Willi.The latest application filed is for "anti-her3 antibodies and uses thereof".
Company Profile
1.21.26
- Krell; Hans-Willi - Penzberg DE
- Krell; Hans-Willi - Monza IT
Patent Activity
| Patent | Date |
|---|---|
| Anti-HER3 antibodies and uses thereof Grant 10,196,456 - Bossenmaier , et al. Fe | 2019-02-05 |
| Anti-her3 Antibodies And Uses Thereof App 20170174784 - Bossenmaier; Birgit ; et al. | 2017-06-22 |
| Method For Obtaining Immunoglobulin Encoding Nucleic Acid App 20170107550 - Krell; Hans-Willi ; et al. | 2017-04-20 |
| Anti-HER3 antibodies and uses thereof Grant 9,611,331 - Bossenmaier , et al. April 4, 2 | 2017-04-04 |
| Method for obtaining immunoglobulin encoding nucleic acid Grant 9,399,670 - Krell , et al. July 26, 2 | 2016-07-26 |
| Use of an anti-Tau pS422 antibody for the treatment of brain diseases Grant 9,290,567 - Bohrmann , et al. March 22, 2 | 2016-03-22 |
| METHOD FOR OBTAINING FAB FRAGMENTS FROM SINGLE ANTIBODY PRODUCING CELLS BY MULTIPLEXED CPR IN COMBINATION WITH TaqMan PROBES App 20150024434 - Krell; Hans-Willi ; et al. | 2015-01-22 |
| Anti-her3 Antibodies And Uses Thereof App 20140377272 - Bossenmaier; Birgit ; et al. | 2014-12-25 |
| Anti-her3 Antibodies And Uses Thereof App 20140377273 - Bossenmaier; Birgit ; et al. | 2014-12-25 |
| Antibodies against CDCP1 for the treatment of cancer Grant 8,883,159 - Bossenmaier , et al. November 11, 2 | 2014-11-11 |
| Anti-HER3 antibodies and uses thereof Grant 8,859,737 - Bossenmaier , et al. October 14, 2 | 2014-10-14 |
| Use of an anti-Tau pS422 antibody for the treatment of brain diseases Grant 8,609,097 - Bohrmann , et al. December 17, 2 | 2013-12-17 |
| Use Of An Anti-tau Ps422 Antibody For The Treatment Of Brain Diseases App 20130310541 - Bohrmann; Bernd ; et al. | 2013-11-21 |
| Antibodies Against Human Ccn1 And Uses Thereof App 20120258112 - Knoetgen; Hendrik ; et al. | 2012-10-11 |
| Antibodies against human CCN1 and uses thereof Grant 8,207,307 - Knoetgen , et al. June 26, 2 | 2012-06-26 |
| Antibodies specifically binding to human TSLPR and methods of use App 20120020988 - AUER; JOHANNES ; et al. | 2012-01-26 |
| Method For Obtaining Immunoglobulin Encoding Nucleic Acid App 20110306094 - Krell; Hans-Willi ; et al. | 2011-12-15 |
| Pharmaceutical compositions of pyrimidine-2,4,6-triones Grant 8,044,035 - Bartsch , et al. October 25, 2 | 2011-10-25 |
| Anti-her3 Antibodies And Uses Thereof App 20110171222 - Bossenmaier; Birgit ; et al. | 2011-07-14 |
| Antibodies Against CDCP1 for the Treatment of Cancer App 20110070246 - Bossenmaier; Birgit ; et al. | 2011-03-24 |
| Use Of An Anti-tau Ps422 Antibody For The Treatment Of Brain Diseases App 20110059093 - Bohrmann; Bernd ; et al. | 2011-03-10 |
| Antibodies Against Human CCN1 and Uses Thereof App 20100310567 - KNOETGEN; HENDRIK ; et al. | 2010-12-09 |
| Pharmaceutical Compositions Of Pyrimidine-2,4,6-triones App 20100261672 - Bartsch; Pierre ; et al. | 2010-10-14 |
| Pyrazole Derivatives, Their Manufacture and Their Use as Pharmaceutical Agents App 20090264485 - Krell; Hans-Willi ; et al. | 2009-10-22 |
| Tricyclic Lactam Derivatives, Their Manufacture and Use as Pharmaceutical Agents App 20090143375 - Georges; Guy ; et al. | 2009-06-04 |
| Phenylpyridine derivatives Grant 7,429,605 - Bossenmaier , et al. September 30, 2 | 2008-09-30 |
| Tricycles, their manufacture and use as pharmaceutical agents Grant 7,285,569 - Guy , et al. October 23, 2 | 2007-10-23 |
| Pharmaceutical compositions of pyrimidine-2,4,6-triones App 20070191404 - Bartsch; Pierre ; et al. | 2007-08-16 |
| Phenylpyridine derivatives App 20070032530 - Bossenmaier; Birgit ; et al. | 2007-02-08 |
| Tricyclic azole derivatives App 20060235013 - Georges; Guy ; et al. | 2006-10-19 |
| Tricycles, their manufacture and use as pharmaceutical agents App 20060069145 - Guy; Georges ; et al. | 2006-03-30 |
| 2-(2,6-Dichlorophenyl)-Diarylimidazoles Grant 6,946,471 - Brandt , et al. September 20, 2 | 2005-09-20 |
| 2-(2,6-Dichlorophenyl)-Diarylimidazoles App 20040214874 - Brandt, Michael ; et al. | 2004-10-28 |
| 2-(2,6-dichlorophenyl)-diarylimidazoles Grant 6,790,852 - Brandt , et al. September 14, 2 | 2004-09-14 |
| Combination of a gelatinase inhibitor and an anti-tumor agent, and uses thereof App 20040132739 - Friess, Thomas ; et al. | 2004-07-08 |
| Barbituric acid derivatives Grant 6,716,845 - Geppert , et al. April 6, 2 | 2004-04-06 |
| 2-(2,6-dichlorophenyl)-diarylimidazoles App 20030199691 - Brandt, Michael ; et al. | 2003-10-23 |
| Barbituric acid derivatives App 20020187991 - Geppert, Dagmar ; et al. | 2002-12-12 |
| Thiazolidinecarboxyl acids App 20020037901 - Friebe, Walter-Gunar ; et al. | 2002-03-28 |
| 3-aminoethyl-n-amidino-2,5-dihydropyrrole Derivatives Having Arginine Mimetic Properties App 20020026034 - ENGH, RICHARD ; et al. | 2002-02-28 |
| Barbituric acid derivatives with antimetastatic and antitumor activity Grant 6,335,332 - Oliva , et al. January 1, 2 | 2002-01-01 |
| Barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds Grant 6,110,924 - Bosies , et al. August 29, 2 | 2000-08-29 |
| Use of derivatives of tetrahydro-beta-carbolines as antimetastatic agents Grant 6,069,150 - Spinelli , et al. May 30, 2 | 2000-05-30 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 